Thermo Fisher Scientific has introduced new solution for proteomics research and announced a series of co-marketing agreements with industry experts, advancing the throughput, comprehensiveness and quality of proteomics workflows for applications such as single-cell studies and translational research.

“Proteomics research has the potential to expand our scientific understanding and uncover new biomarkers to meet unmet medical needs,” said Andreas Huhmer, senior director, life sciences research omics marketing, Thermo Fisher Scientific. “While there has been significant progress in our ability to perform advanced analyses such as single-cell and translational proteomics, there are still improvements needed in the efficiency and reproducibility of workflows. The agreements will enable us to continue to deliver innovative proteomics solutions to customers with a goal to make these workflows accessible to everyone.”

Thermo Fisher is extending their co-marketing agreement with Biognosys, a leading developer of next-generation proteomics solutions, to provide laboratories performing high-throughput plasma analysis with innovative and streamlined instruments, kits and software to enable efficient and accurate workflows at scale. The PQ500 Reference Peptide Kit from Biognosys is able to quantify more than 500 proteins in human plasma/serum samples as part of the SureQuant IS-PRM workflow, enabled only with the Thermo Scientific Orbitrap Exploris 480 mass spectrometer, delivering sensitive and accurate quantitation to drive scientific progress or clinical decision making. Biognosys’ SpectroDive software extends research applications to targeted proteomics enabling automated MS method set-up, signal processing and analysis of targeted experiments, such as the SureQuant IS-PRM workflow.

New liquid chromatography solution

The new Thermo Scientific Vanquish Neo Ultra-High Performance Liquid Chromatography (UHPLC) System complements high-resolution Thermo Scientific Orbitrap mass spectrometry for proteomics analyses, minimizing sample loss and delivering the highest quality of data. The new system is designed for high-sensitivity LC-MS applications, with excellent analytical performance at flow rates from 1 nL/min to 100 µL/min up to 1500 bar. The separation capabilities and reproducibility of this all-in-one nano-, capillary- and micro-flow LC system will help users to overcome limitations of existing low-flow LC instruments.

Thermo Fisher has also extended its chromatography portfolio through the acquisition of Belgium-based PharmaFluidics, the developer of the μPAC range of micro-chip-based chromatography columns. The µPAC portfolio of columns enhance LC performance in biomarker, proteomics and drug research and development applications, helping biotechnology and pharmaceutical companies uncover new insights and advance scientific discovery.

One of Thermo Fisher’s goals is to provide customers with a platform to effectively and efficiently analyse thousands of single cells. A co-marketing agreement between Thermo Fisher and Cellenion, experts in single-cell sample preparation solutions, will deliver a full workflow, from sample to results, for scientists performing single-cell proteomics analysis. Laborious sample preparation has typically held back single-cell MS methods. To overcome this, Cellenion’s sample preparation solution, cellenONE, combines single-cell isolation and nanolitre dispensing to perform every step of the sample preparation using a single device. With single-cell proteomics providing vital information on the state of individual cells within heterogeneous environments, the combination of this sample preparation technology with Thermo Fisher’s TMT multiplexing technologies and Orbitrap mass spectrometers will open new doors for researchers.

• For more information, visit: thermofisher.com/proteomics

Regular colony counts are part of the day-to-day tasks of many laboratories in order to rule out the contamination of products with bacteria, viruses, yeasts, or moulds during production. To do this, Petri dishes containing the relevant samples are evaluated in order to determine the number of colonies formed. While the classic manual counting method means that every single colony has to be marked individually, automatic devices can analyse numerous Petri dishes of the same type very quickly. However, this requires time-consuming programming and preparation that may not be feasible if there is a small number of samples amounting to just a few Petri dishes a day.

The ColonyStar automatic from Funke-Gerber resolves this issue. The device, which is equipped with a camera and a cordless, detachable tablet, makes the analysis of Petri dishes both fast and straightforward. The unique assist mode is particularly helpful: After tapping on a colony via touchscreen, other colonies of the same type are automatically recorded, marked, and counted. The selection can be corrected at any time. In this way, the lab worker retains full control while also achieving huge time savings.

Total bacterial count

In hygiene management and quality control, the total bacterial count is one of the most important parameters. It states how many micro-organisms are contained within a sample. Depending on the type of micro-organism, there are limits that may not be exceeded in order to protect consumers from diseases such as food poisoning. As a result, samples are routinely cultured on Petri dishes in order to be able to determine the micro-organism concentration after a certain period via a colony count. Older devices in particular, however, that required the counting of every colony individually using a light table and microscope, made this task a time-consuming ordeal.

“A Petri dish like this, if it is processed at the right dilution, has between 150 and 200 colonies,” explains Konrad Schäfer, CEO of Funke-Dr. N. Gerber Labortechnik GmbH. “If they have to be counted manually, the person counting has to maintain their concentration and mark each colony individually. A routine task can quickly become a time-consuming endeavour.”

The previous method for colony counting also does not allow for the markings to be changed, which increases the risk of some colonies being counted twice. Automatic devices are more reliable but they are generally designed to handle larger batches and require a certain amount of effort to be invested beforehand.

“As a result of their complexity, such systems are a major financial investment. On the other hand, time-consuming preparations are necessary in order to program them because colony diameters or maximum/minimum contrast must be defined prior to automatic operation,” says Schäfer.

The ColonyStar automatic from Funke-Gerber, however, has been developed so that the device significantly accelerates manual counting with a semi-automatic counting mode. In order to mark 200 colonies, for example, only between four and 15 actions are necessary. The device operator retains complete control and does not have to rely solely on the device, as is the case with fully automatic solutions. In addition to this assist mode, the system can still be trained to identify selected colonies so that fully automatic colony counts can be conducted on predefined samples.

Additionally, the device features a fully automatic counting mode. The system can also be trained to recognize certain strains of bacteria and agar media. To do this, you can analyse ten to 15 Petri dishes containing the same species on the same agar media and then, after the learning phase, save it as a profile, such as Salmonella or yeast. Colonies of the same type that match these can then be analyzed fully automatically.

• For more information, visit: funke-gerber.de

Drawing upon over 30-years’ experience of serving the glycobiology research community, AMSBIO has established a comprehensive portfolio of high-quality reagents including unique ranges of antibodies, lectins, enzymes, assay kits and standards, backed by in-depth technical support.

Glycobiology (the study of the structure, biosynthesis, and biology of carbohydrates) is a complex and dynamic area of research that combines enzymology, molecular and cellular biology, organic chemistry and materials science. Widely acknowledged as critical for both cellular biology and studies of carbohydrate-based drugs and therapeutics, glycobiology is a rapidly expanding field of research that is attracting a lot of attention.

Dr William Hadlington-Booth, Glycobiology product manager commented: “To maintain our global reputation as the premier supplier for the glycobiology research community, we’re constantly introducing new leading-edge products as well as investing in inventory to help us supply researchers with key reagents when they need them.”

Working with leading research groups – AMSBIO has established an unmatched range of monoclonal antibodies and binding proteins for proteoglycan, glycosaminoglycan (GAG) and ganglioside research including Heparan Sulfate, Chondroitin Sulfate, Keratan Sulfate and Hyaluronic Acid. AMSBIO’s antibodies provide high levels of specificity and affinity to target antigens; and most glycobiology antibodies work across many model species.

AMSBIO also offers a comprehensive range of specialist enzymes for glycobiology research and other applications. The company’s glycosaminoglycan (GAG) degrading enzymes include chondroitinase, heparinase and hyaluronidase enzymes.

The enzymes heparanase and hyaluronidase both play essential roles degrading carbohydrates in the extracellular matrix; and chondroitinase ABC has been associated with promoting neural repair and plasticity. AMSBIO offers kits for measuring activity of these enzymes in cell culture supernatants, plasma and other biological fluids, and tissue samples. These kits have been widely used by leading research groups for studies on anti-inflammatory responses, kidney disease, and cancer as they solve the standardization and performance issues associated with traditional measurement techniques for these types of enzymes.

• For more information, visit:  amsbio.com/research-areas/glycobiology

TRIMERO Diagnostics offers, under the brand KLoneus®, IVD CE marked nephelometric assays for testing FREE LIGHT CHAINS (FLC) on Beckman Coulter’s IMMAGE® Immunochemical Systems.